Daily Costs and Cost Effectiveness of Glaucoma Fixed Combinations in China

BACKGROUND: The aim of this study was to compare the daily costs and cost effectiveness of fixed combination glaucoma drugs in China. METHODS: This study included the following fixed combination drugs: brinzolamide 1% and timolol 0.5% (Azarga; Alcon, Inc., Fort Worth, TX, USA), travoprost 0.004% and...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Chenjia, Guo, Ruru, Huang, Dandan, Ji, Jian, Liu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436355/
https://www.ncbi.nlm.nih.gov/pubmed/32850141
http://dx.doi.org/10.1155/2020/2406783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436355/
https://www.ncbi.nlm.nih.gov/pubmed/32850141
http://dx.doi.org/10.1155/2020/2406783

Ejemplares similares